Isis Pharmaceuticals Enterprise Value:
1.928B for May 17, 2013Isis Pharmaceuticals Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 17, 2013 | 1.928B |
| May 16, 2013 | 1.876B |
| May 15, 2013 | 1.929B |
| May 14, 2013 | 1.885B |
| May 13, 2013 | 1.797B |
| May 10, 2013 | 1.759B |
| May 9, 2013 | 1.705B |
| May 8, 2013 | 1.824B |
| May 7, 2013 | 2.054B |
| May 6, 2013 | 2.108B |
| May 3, 2013 | 2.108B |
| May 2, 2013 | 2.105B |
| May 1, 2013 | 2.015B |
| April 30, 2013 | 2.105B |
| April 29, 2013 | 2.128B |
| April 26, 2013 | 2.113B |
| April 25, 2013 | 2.110B |
| April 24, 2013 | 2.100B |
| April 23, 2013 | 2.082B |
| April 22, 2013 | 2.046B |
| April 19, 2013 | 1.973B |
| April 18, 2013 | 1.799B |
| April 17, 2013 | 1.776B |
| April 16, 2013 | 1.763B |
| April 15, 2013 | 1.694B |
| April 12, 2013 | 1.777B |
| April 11, 2013 | 1.779B |
| April 10, 2013 | 1.685B |
| April 9, 2013 | 1.607B |
| April 8, 2013 | 1.590B |
| April 5, 2013 | 1.587B |
| April 4, 2013 | 1.530B |
| April 3, 2013 | 1.479B |
| April 2, 2013 | 1.528B |
| April 1, 2013 | 1.554B |
| March 28, 2013 | 1.433B |
| March 27, 2013 | 1.475B |
| March 26, 2013 | 1.421B |
| March 25, 2013 | 1.439B |
| March 22, 2013 | 1.422B |
| March 21, 2013 | 1.538B |
| March 20, 2013 | 1.525B |
| March 19, 2013 | 1.496B |
| March 18, 2013 | 1.504B |
| March 15, 2013 | 1.507B |
| March 14, 2013 | 1.515B |
| March 13, 2013 | 1.507B |
| March 12, 2013 | 1.535B |
| March 11, 2013 | 1.511B |
| March 8, 2013 | 1.511B |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
ISIS Enterprise Value Benchmarks
| Companies | |
|---|---|
| Aegerion Pharmaceuticals | 1.643B |
| Sanofi | 156.90B |
| Biogen Idec | 53.86B |
ISIS Enterprise Value Rankings
| Overall |
78th percentile 1610 of 7593 |
| Sector |
80th percentile 130 of 650 in Healthcare |
| Industry |
89th percentile 24 of 237 in Biotechnology |
ISIS Enterprise Value Range, Past 5 Years
| Minimum | 398.72M | Aug 23 2010 |
| Maximum | 2.128B | Apr 29 2013 |
| Average | 853.18M |
